C4 Therapeutics, Inc. - CCCC

All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)? Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).

Files summary

Total files loaded: 29
Latest filed: Jun 04, 2026
Form Count
4 13
SCHEDULE 13G/A 6
8-K 6
144 2
SCHEDULE 13G 2

Latest files

Filed Form Report period Accession SEC
Jun 04, 2026 4 Jun 01, 2026 0001470831-26-000504 View
May 28, 2026 144 0001193125-26-245847 View
May 19, 2026 SCHEDULE 13G 0002050709-26-000018 View
May 15, 2026 SCHEDULE 13G/A 0000919574-26-003479 View
May 15, 2026 8-K May 15, 2026 0001628280-26-035542 View
May 15, 2026 SCHEDULE 13G 0000919574-26-003216 View
May 12, 2026 8-K May 12, 2026 0001628280-26-033861 View
Apr 22, 2026 SCHEDULE 13G/A 0000814133-26-000050 View
Apr 10, 2026 8-K Apr 10, 2026 0001628280-26-024583 View
Apr 09, 2026 8-K Apr 09, 2026 0001628280-26-024336 View
Apr 03, 2026 4 Apr 01, 2026 0001470831-26-000345 View
Apr 03, 2026 4 Apr 01, 2026 0001470831-26-000346 View
Mar 09, 2026 144 0001950047-26-002361 View
Feb 26, 2026 8-K Feb 26, 2026 0001628280-26-011971 View
Feb 18, 2026 4 Feb 13, 2026 0001470831-26-000174 View
Feb 18, 2026 4 Feb 13, 2026 0001470831-26-000175 View
Feb 18, 2026 4 Feb 13, 2026 0001470831-26-000176 View
Feb 18, 2026 4 Feb 13, 2026 0001470831-26-000177 View
Feb 18, 2026 4 Feb 13, 2026 0001470831-26-000178 View
Feb 18, 2026 4 Feb 13, 2026 0001470831-26-000179 View
Feb 18, 2026 4 Feb 13, 2026 0001470831-26-000180 View
Feb 17, 2026 SCHEDULE 13G/A 0000902664-26-001046 View
Feb 17, 2026 SCHEDULE 13G/A 0000947871-26-000188 View
Feb 12, 2026 SCHEDULE 13G/A 0001213900-26-015656 View
Feb 11, 2026 SCHEDULE 13G/A 0000895421-26-000033 View
Jan 16, 2026 4 Jan 16, 2026 0001470831-26-000045 View
Jan 14, 2026 8-K Jan 14, 2026 0001628280-26-002010 View
Jan 05, 2026 4 Jan 02, 2026 0001470831-26-000008 View
Jan 05, 2026 4 Jan 02, 2026 0001470831-26-000009 View